Petri M - Search Results

1

Validity and reliability of lupus activity measures in the routine clinic setting.

Petri M, Hellmann D, Hochberg M. Petri M, et al. J Rheumatol. 1992 Jan;19(1):53-9. J Rheumatol. 1992. PMID: 1556700

2

Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.

Pejchinovski M, Siwy J, Mullen W, Mischak H, Petri MA, Burkly LC, Wei R. Pejchinovski M, et al. Among authors: petri ma. Lupus. 2018 Jan;27(1):6-16. doi: 10.1177/0961203317707827. Epub 2017 May 5. Lupus. 2018. PMID: 28474961 Free PMC article.

3

Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod.

Petri MA, Martin RS, Scheinberg MA, Furie RA. Petri MA, et al. Lupus. 2017 Jan;26(1):27-37. doi: 10.1177/0961203316654767. Epub 2016 Jun 26. Lupus. 2017. PMID: 27353505 Clinical Trial.

4

Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.

Martins M, Williams AH, Comeau M, Marion M, Ziegler JT, Freedman BI, Merrill JT, Glenn SB, Kelly JA, Sivils KM, James JA, Guthridge JM, Alarcón-Riquelme ME, Bae SC, Kim JH, Kim D, Anaya JM, Boackle SA, Criswell LA, Kimberly RP, Alarcón GS, Brown EE, Vilá LM, Petri MA, Ramsey-Goldman R, Niewold TB, Tsao BP, Gilkeson GS, Kamen DL, Jacob CO, Stevens AM, Gaffney PM, Harley JB, Langefeld CD, Fesel C. Martins M, et al. Among authors: petri ma. Genes Immun. 2015 Mar;16(2):142-50. doi: 10.1038/gene.2014.73. Epub 2015 Jan 8. Genes Immun. 2015. PMID: 25569266 Free PMC article.

5

A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study.

Furie RA, Leon G, Thomas M, Petri MA, Chu AD, Hislop C, Martin RS, Scheinberg MA; PEARL-SC Study. Furie RA, et al. Among authors: petri ma. Ann Rheum Dis. 2015 Sep;74(9):1667-75. doi: 10.1136/annrheumdis-2013-205144. Epub 2014 Apr 19. Ann Rheum Dis. 2015. PMID: 24748629 Clinical Trial.

6

Lupus Atherosclerosis Prevention Study (LAPS).

Petri MA, Kiani AN, Post W, Christopher-Stine L, Magder LS. Petri MA, et al. Ann Rheum Dis. 2011 May;70(5):760-5. doi: 10.1136/ard.2010.136762. Epub 2010 Dec 21. Ann Rheum Dis. 2011. PMID: 21177297 Clinical Trial.

7

Oral candidiasis in systemic lupus erythematosus.

Fangtham M, Magder LS, Petri MA. Fangtham M, et al. Among authors: petri ma. Lupus. 2014 Jun;23(7):684-90. doi: 10.1177/0961203314525247. Epub 2014 Mar 5. Lupus. 2014. PMID: 24598219

8

Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group.

Clarke AE, Penrod J, St Pierre Y, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal JL, Fortin PR, Sutcliffe N, Goulet JR, Choquette D, Grodzicky T, Esdaile JM. Clarke AE, et al. Among authors: petri ma. J Rheumatol. 2000 Nov;27(11):2597-604. J Rheumatol. 2000. PMID: 11093439

9

C4A deficiency due to a 2 bp insertion is increased in patients with systemic lupus erythematosus.

Sullivan KE, Kim NA, Goldman D, Petri MA. Sullivan KE, et al. Among authors: petri ma. J Rheumatol. 1999 Oct;26(10):2144-7. J Rheumatol. 1999. PMID: 10529130

10

An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group.

Clarke AE, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal JL, St Pierre Y, Joseph L, Penrod J, Fortin PR, Sutcliffe N, Goulet JR, Choquette D, Grodzicky T, Danoff DS, Ho V, Esdaile JM. Clarke AE, et al. Among authors: petri ma. J Rheumatol. 1999 Jul;26(7):1500-11. J Rheumatol. 1999. PMID: 10405937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results